The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.8M data for 1.2M Compounds and 9.2K Targets. Of those, 1,339K data for 617K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

107 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Synthesis and bioevaluation of novel benzodipyranone derivatives as P-glycoprotein inhibitors for multidrug resistance reversal agents.EBI
China Medical University
Structure-activity relationships of dibenzoylhydrazines for the inhibition of P-glycoprotein-mediated quinidine transport.EBI
Kyoto University
The combination of quinazoline and chalcone moieties leads to novel potent heterodimeric modulators of breast cancer resistance protein (BCRP/ABCG2).EBI
University Of Bonn
Optimization by Molecular Fine Tuning of Dihydro-ß-agarofuran Sesquiterpenoids as Reversers of P-Glycoprotein-Mediated Multidrug Resistance.EBI
Instituto Universitario De Bio-Org£Nica&Quot;Antonio Gonz£Lez&Quot
Flavonoid derivatives as selective ABCC1 modulators: Synthesis and functional characterization.EBI
University Of Regensburg
The interaction of 4-thiazolidinone derivatives containing indolin-2-one moiety with P-glycoprotein studied using K562 cell lines.EBI
The First Affiliated Hospital Of Dalian Medical University
Optimization of permethyl ningalin B analogs as P-glycoprotein inhibitors.EBI
Ocean University Of China
Discovery of substituted 1,4-dihydroquinolines as novel promising class of P-glycoprotein inhibitors: First structure-activity relationships and bioanalytical studies.EBI
Martin-Luther-University Halle-Wittenberg
Potent and Nontoxic Chemosensitizer of P-Glycoprotein-Mediated Multidrug Resistance in Cancer: Synthesis and Evaluation of Methylated Epigallocatechin, Gallocatechin, and Dihydromyricetin Derivatives.EBI
The Hong Kong Polytechnic University
Restoration of Chemosensitivity in P-Glycoprotein-Dependent Multidrug-Resistant Cells by Dihydro-ß-agarofuran Sesquiterpenes from Celastrus vulcanicola.EBI
Instituto Universitario De Bio-Org£Nica Antonio Gonz£Lez (Iubo-Ag)
In vitro investigations into the roles of drug transporters and metabolizing enzymes in the disposition and drug interactions of dolutegravir, a HIV integrase inhibitor.EBI
Glaxosmithkline
HM30181 Derivatives as Novel Potent and Selective Inhibitors of the Breast Cancer Resistance Protein (BCRP/ABCG2).EBI
University Of Bonn
Trimethoxybenzanilide-based P-glycoprotein modulators: an interesting case of lipophilicity tuning by intramolecular hydrogen bonding.EBI
Universit£
Investigating the binding interactions of the anti-Alzheimer's drug donepezil with CYP3A4 and P-glycoprotein.EBI
University Of Waterloo
Deconstruction of 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline moiety to separate P-glycoprotein (P-gp) activity froms2 receptor affinity in mixed P-gp/s2 receptor agents.EBI
Universit£
SAR studies on tetrahydroisoquinoline derivatives: the role of flexibility and bioisosterism to raise potency and selectivity toward P-glycoprotein.EBI
Universit£
Potent nonimmunosuppressive cyclophilin inhibitors with improved pharmaceutical properties and decreased transporter inhibition.EBI
Novartis Institutes For Biomedical Research
4,5-Di-substituted benzyl-imidazol-2-substituted amines as the structure template for the design and synthesis of reversal agents against P-gp-mediated multidrug resistance breast cancer cells.EBI
Ocean University Of China
Design and synthesis of human ABCB1 (P-glycoprotein) inhibitors by peptide coupling of diverse chemical scaffolds on carboxyl and amino termini of (S)-valine-derived thiazole amino acid.EBI
St. John'S University
Synthesis, biological evaluation and 3D-QSAR studies of new chalcone derivatives as inhibitors of human P-glycoprotein.EBI
Medical University Vienna
SAR study on arylmethyloxyphenyl scaffold: looking for a P-gp nanomolar affinity.EBI
Universit£
Investigation of quinazolines as inhibitors of breast cancer resistance protein (ABCG2).EBI
University Of Bonn
Development of 3,4-dihydroisoquinolin-1(2H)-one derivatives for the Positron Emission Tomography (PET) imaging ofs2 receptors.EBI
Universit£
Synthesis of N(4)-(substituted phenyl)-N(4)-alkyl/desalkyl-9H-pyrimido[4,5-b]indole-2,4-diamines and identification of new microtubule disrupting compounds that are effective against multidrug resistant cells.EBI
Duquesne University
Potent and selective tariquidar bioisosters as potential PET radiotracers for imaging P-gp.EBI
Universit£
Naphthalenyl derivatives for hitting P-gp/MRP1/BCRP transporters.EBI
Universit£
Benzanilide-Biphenyl Replacement: A Bioisosteric Approach to Quinoline Carboxamide-Type ABCG2 Modulators.EBI
University Of Regensburg
Docking and 3D-QSAR (quantitative structure activity relationship) studies of flavones, the potent inhibitors of p-glycoprotein targeting the nucleotide binding domain.EBI
Chosun University
Intrinsic and acquired forms of resistance against the anticancer ruthenium compound KP1019 [indazolium trans-[tetrachlorobis(1H-indazole)ruthenate (III)] (FFC14A).EBI
Institute Of Cancer Research
Transport characteristics of fexofenadine in the Caco-2 cell model.EBI
Uppsala University
Inhibitory effects of a cyclosporin derivative, SDZ PSC 833, on transport of doxorubicin and vinblastine via human P-glycoprotein.EBI
Kobe University
Inhibitory potencies of 1,4-dihydropyridine calcium antagonists to P-glycoprotein-mediated transport: comparison with the effects on CYP3A4.EBI
Kanazawa University
Inhibitory effects of CYP3A4 substrates and their metabolites on P-glycoprotein-mediated transport.EBI
Kanazawa University
Cepharanthin, a multidrug resistant modifier, is a substrate for P-glycoprotein.EBI
Kyoto University Hospital
Ranking of P-glycoprotein substrates and inhibitors by a calcein-AM fluorometry screening assay.EBI
Strasbourg 1 University
Are MDCK cells transfected with the human MDR1 gene a good model of the human intestinal mucosa?EBI
The University Of Kansas
HMG-CoA reductase inhibitors (statins) characterized as direct inhibitors of P-glycoprotein.EBI
Schering-Plough Research Institute
Quantitative distinctions of active site molecular recognition by P-glycoprotein and cytochrome P450 3A4.EBI
Schering-Plough Research Institute
The farnesyl protein transferase inhibitor SCH66336 is a potent inhibitor of MDR1 product P-glycoprotein.EBI
Schering-Plough Research Institute
Cholesterol interaction with the daunorubicin binding site of P-glycoprotein.EBI
Schering-Plough Research Institute
P-glycoprotein interactions of nefazodone and trazodone in cell culture.EBI
Tufts University School Of Medicine
Methadone inhibits rhodamine123 transport in Caco-2 cells.EBI
Tufts University School Of Medicine
Evaluation of the interaction of loratadine and desloratadine with P-glycoprotein.EBI
Schering-Plough Research Institute
Active transport of fluorescent P-glycoprotein substrates: evaluation as markers and interaction with inhibitors.EBI
Schering-Plough Research Institute
Interaction of common azole antifungals with P glycoprotein.EBI
Schering-Plough Research Institute
Pharmacological inhibition of P-glycoprotein transport enhances the distribution of HIV-1 protease inhibitors into brain and testes.EBI
Vanderbilt University School Of Medicine
Lopinavir: acute exposure inhibits P-glycoprotein; extended exposure induces P-glycoprotein.EBI
Tufts University School Of Medicine
Mibefradil is a P-glycoprotein substrate and a potent inhibitor of both P-glycoprotein and CYP3A in vitro.EBI
Vanderbilt University School Of Medicine
Interaction of morphine, fentanyl, sufentanil, alfentanil, and loperamide with the efflux drug transporter P-glycoprotein.EBI
Vanderbilt University
Interaction of omeprazole, lansoprazole and pantoprazole with P-glycoprotein.EBI
Institute Of Clinical Pharmacology
Characterization of the major metabolites of verapamil as substrates and inhibitors of P-glycoprotein.EBI
Dr. Margarete Fischer-Bosch-Institute Of Clinical Pharmacology
Inhibition of the P-glycoprotein- and multidrug resistance protein-mediated efflux of anthracyclines and calceinacetoxymethyl ester by PAK-104P.EBI
Universit£
Reversal of P-glycoprotein-mediated MDR by 5,7,3',4',5'-pentamethoxyflavone and SAR.EBI
Chosun University
Differential interaction of 3-hydroxy-3-methylglutaryl-coa reductase inhibitors with ABCB1, ABCC2, and OATP1B1.EBI
Pfizer
Differential effects of the optical isomers of KR30031 on cardiotoxicity and on multidrug resistance reversal activity.EBI
Korea Research Institute Of Chemical Technology
Imaging reversal of multidrug resistance in living mice with bioluminescence: MDR1 P-glycoprotein transports coelenterazine.EBI
Washington University
Selectivity of the multidrug resistance modulator, LY335979, for P-glycoprotein and effect on cytochrome P-450 activities.EBI
Eli Lilly
New functional assay of P-glycoprotein activity using Hoechst 33342.EBI
University Of Bonn
New potent P-glycoprotein inhibitors carrying a polycyclic scaffold.EBI
University Of Bologna
Increased anti-P-glycoprotein activity of baicalein by alkylation on the A ring.EBI
Yale University
C-7 analogues of progesterone as potent inhibitors of the P-glycoprotein efflux pump.EBI
Georgetown University School Of Medicine
Synthesis and evaluation of hapalosin and analogs as MDR-reversing agents.EBI
Eisai Research Institute
Thiorhodamines containing amide and thioamide functionality as inhibitors of the ATP-binding cassette drug transporter P-glycoprotein (ABCB1).EBI
The State University Of New York
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.EBI
Uppsala University
Pharmacokinetics and interactions of a novel antagonist of chemokine receptor 5 (CCR5) with ritonavir in rats and monkeys: role of CYP3A and P-glycoprotein.EBI
Merck Research Laboratories
Three-dimensional quantitative structure-activity relationships of inhibitors of P-glycoprotein.EBI
Eli Lilly
Effect of modulators on the ATPase activity and vanadate nucleotide trapping of human P-glycoprotein.EBI
Eli Lilly
Piperine, a major constituent of black pepper, inhibits human P-glycoprotein and CYP3A4.EBI
Dr. Margarete Fischer-Bosch-Institute Of Clinical Pharmacology
PSC833, cyclosporin A, and dexniguldipine effects on cellular calcein retention and inhibition of the multidrug resistance pump in human leukemic lymphoblasts.EBI
University Of Tennessee Medical Center
Nonclinical pharmacokinetics of oseltamivir and oseltamivir carboxylate in the central nervous system.EBI
F. Hoffmann-La Roche
From taxuspine x to structurally simplified taxanes with remarkable p-glycoprotein inhibitory activity.EBI
TBA
Effects of human immunodeficiency virus protease inhibitors on the intestinal absorption of tenofovir disoproxil fumarate in vitro.EBI
Gilead Sciences
Potent and selective inhibitors of breast cancer resistance protein (ABCG2) derived from the p-glycoprotein (ABCB1) modulator tariquidar.EBI
University Of Regensburg
Functional assay and structure-activity relationships of new third-generation P-glycoprotein inhibitors.EBI
University Of Bonn
Small P-gp modulating molecules: SAR studies on tetrahydroisoquinoline derivatives.EBI
Universit£
Synthesis and biological evaluation of (hetero)arylmethyloxy- and arylmethylamine-phenyl derivatives as potent P-glycoprotein modulating agents.EBI
Universita Degli Studi Di Bari
Self-organizing maps for identification of new inhibitors of P-glycoprotein.EBI
University Of Vienna
Identification of a terphenyl derivative that blocks the cell cycle in the G0-G1 phase and induces differentiation in leukemia cells.EBI
Universit£
Comparison of in vitro P-glycoprotein screening assays: recommendations for their use in drug discovery.EBI
F. Hoffmann-La Roche
Pharmacophore model of drugs involved in P-glycoprotein multidrug resistance: explanation of structural variety (hypothesis).EBI
Bulgarian Academy Of Sciences
Cyclosporins: structure-activity relationships for the inhibition of the human MDR1 P-glycoprotein ABC transporter.EBI
Strasbourg 1 University
Aureobasidins: structure-activity relationships for the inhibition of the human MDR1 P-glycoprotein ABC-transporter.EBI
Strasbourg 1 University
Substituted 4-acylpyrazoles and 4-acylpyrazolones: synthesis and multidrug resistance-modulating activity.EBI
University Of Vienna
Potent galloyl-based selective modulators targeting multidrug resistance associated protein 1 and P-glycoprotein.EBI
Universit£
Overcoming human P-glycoprotein-dependent multidrug resistance with novel dihydro-ß-agarofuran sesquiterpenes.EBI
Instituto Universitario De Bio-Org£Nica Antonio Gonz£Lez (Iubo-Ag)
Solid phase synthesis of tariquidar-related modulators of ABC transporters preferring breast cancer resistance protein (ABCG2).EBI
Universidad Nacional De Colombia
A novel approach for predicting P-glycoprotein (ABCB1) inhibition using molecular interaction fields.EBI
University Of Perugia
Interaction potential of etravirine with drug transporters assessed in vitro.EBI
University Hospital Heidelberg
Structure-activity relationships of flavonoids as inhibitors of breast cancer resistance protein (BCRP).EBI
University Of Bonn
Potent and fully noncompetitive peptidomimetic inhibitor of multidrug resistance P-glycoprotein.EBI
Umr 5086 Cnrs
Phenylsulfonylfuroxans as modulators of multidrug-resistance-associated protein-1 and P-glycoprotein.EBI
Universita Degli Studi Di Torino
Antimalarial and antitrypanosomal activity of a series of amide and sulfonamide derivatives of a 2,5-diaminobenzophenone.EBI
Philipps-Universit£T Marburg
Rhodamine inhibitors of P-glycoprotein: an amide/thioamide"switch" for ATPase activity.EBI
The State University Of New York
2-[(3-Methoxyphenylethyl)phenoxy]-based ABCB1 inhibitors: effect of different basic side-chains on their biological properties.EBI
Universita Degli Studi Di Bari
Bis-pyranobenzoquinones as a new family of reversal agents of the multidrug resistance phenotype mediated by P-glycoprotein in mammalian cells and the protozoan parasite Leishmania.EBI
Instituto Universitario De Bio-OrgáNica Antonio GonzáLez
Effect of some P-glycoprotein modulators on Rhodamine-123 absorption in guinea-pig ileum.EBI
Università
Biological evaluation, structure-activity relationships, and three-dimensional quantitative structure-activity relationship studies of dihydro-beta-agarofuran sesquiterpenes as modulators of P-glycoprotein-dependent multidrug resistance.EBI
Instituto Universitario De Bio-Organica Antonio Gonzalez
In vitro activity of novel dual action MDR anthranilamide modulators with inhibitory activity on CYP-450 (Part 2).EBI
Université
Arylmethyloxyphenyl derivatives: small molecules displaying P-glycoprotein inhibition.EBI
Università
Biological evaluation of bishydroxymethyl-substituted cage dimeric 1,4-dihydropyridines as a novel class of p-glycoprotein modulating agents in cancer cells.EBI
Martin-Luther-University Halle-Wittenberg
Synthesis, in vitro and in vivo evaluation of [O-methyl-11C] 2-{4-[4-(3-methoxyphenyl)piperazin-1-yl]-butyl}-4-methyl-2H-[1,2,4]-triazine-3,5-dione: a novel agonist 5-HT1A receptor PET ligand.EBI
Columbia University College Of Physicians And Surgeons
Synthesis and in vivo validation of [O-methyl-11C]2-{4-[4-(7-methoxynaphthalen-1-yl)piperazin- 1-yl]butyl}-4-methyl-2H-[1,2,4]triazine-3,5-dione: a novel 5-HT1A receptor agonist positron emission tomography ligand.EBI
Columbia University College Of Physicians And Surgeons
Tricyclic isoxazoles are novel inhibitors of the multidrug resistance protein (MRP1).EBI
Eli Lilly
 
Cycloalkylpiperazines as HIV-1 Protease Inhibitors: Enhanced Oral AbsorptionBDB
Merck Research Laboratories